Coral Springs, FL3 Active Studies

Myeloproliferative Neoplasms Clinical Trials in Coral Springs, FL

Find 3 actively recruiting myeloproliferative neoplasms clinical trials in Coral Springs, FL. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
502
Enrolling

Recruiting Myeloproliferative Neoplasms Studies in Coral Springs

About Myeloproliferative Neoplasms Clinical Trials in Coral Springs

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 3 myeloproliferative neoplasms clinical trials recruiting participants in Coral Springs, FL. These studies are seeking a combined 502 participants. Research is being sponsored by Takeda, Prelude Therapeutics, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in Coral Springs — FAQ

Are there myeloproliferative neoplasms clinical trials in Coral Springs?

Yes, there are 3 myeloproliferative neoplasms clinical trials currently recruiting in Coral Springs, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Coral Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Coral Springs research site will contact you about next steps.

Are clinical trials in Coral Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Coral Springs studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 3 active trials in Coral Springs are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated October 12, 2026 from ClinicalTrials.gov